EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand

Erica E Zeno iD, Prabda Praphasiri, Wichan Bhunyakitikorn, Sutthichai Nakphook, Darunee Ditsungnoen, Wuttiphong Phakdeekul, Passakorn Ongarj, Ratchadaporn Ungcharoen, Warinmad Kedthongma, Seesai Yeesoonsang, Kanlaya Sornwong, Chaninan Sonthichai und 4 weitere

American Journal of Epidemiology · 2026

DOI: 10.1093/aje/kwag094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2026. Verfasst von Erica E Zeno und 15 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, United Sta…. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Vaccine Efficacy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Public Health in the Kingdom of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thailand uses a test-negative design to calculate influenza vaccine effectiveness (VE) annually for the Southern Hemisphere formulation and shares estimates with the World Health Organization to inform global vaccine strain selection. This study analyzed potential misclassification and confounding factors to evaluate validity of the test-negative design in Thailand. We retrospectively reviewed influenza sentinel surveillance data from June 2023 to May 2024 and gathered information on vaccination history and health-seeking behavior. Cases were medically attended illnesses with positive influenza test results; noncases had negative results for influenza and SARS-CoV-2. We compared VE using the routine approach with six scenarios, representing four potential threats to the validity of test-negative design studies. We assessed exposure (vaccination) misclassification, outcome (influenza) misclassification, and confounding by health-seeking behavior. Unmeasured confounding was evaluated by calculating VE against rhinovirus, an outcome unrelated to influenza vaccination. A total of 4709 patients were included, of which 328 (7.0%) were vaccinated against influenza. Under the routine approach, VE against medically attended influenza was 36.9% (95% CI, 13.5%-53.9%). In alternative scenarios, VE ranged from 32.4% to 42.8%, with overlapping 95% CIs. These findings support the validity of Thailand’s VE estimates and can inform improvements in surveillance procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanVaccine EfficacyHumansThailandFemaleSentinel SurveillanceRetrospective StudiesMaleAdultMiddle AgedAdolescentChildYoung AdultChild, PreschoolReproducibility of ResultsAged

Stichwörter der Autor:innen

influenzatest-negative designvaccine effectiveness

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
  • Faculty of Public Health, Kasetsart University Chalermphrakiat Sakon Nakhon Province Campus, Sakon Nakhon Province, Thailand.
  • Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
  • Nakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand.

ORCID-Profile: Erica E Zeno

Förderung

  • Ministry of Public Health in the Kingdom of Thailand

Zitieren

APA

Zeno, E. E., Praphasiri, P., Bhunyakitikorn, W., Nakphook, S., Ditsungnoen, D., Phakdeekul, W., Ongarj, P., Ungcharoen, R., Kedthongma, W., Yeesoonsang, S., Sornwong, K., Sonthichai, C., Chard, A. N., Davis, W. W., Montgomery, M. P., & Prasert, K. (2026). Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwag094

Vancouver

Zeno EE, Praphasiri P, Bhunyakitikorn W, Nakphook S, Ditsungnoen D, Phakdeekul W, et al. Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand. American Journal of Epidemiology. 2026. doi:10.1093/aje/kwag094

BibTeX
@article{Zeno2026,
  author = {Zeno, Erica E and Praphasiri, Prabda and Bhunyakitikorn, Wichan and Nakphook, Sutthichai and Ditsungnoen, Darunee and Phakdeekul, Wuttiphong and Ongarj, Passakorn and Ungcharoen, Ratchadaporn and Kedthongma, Warinmad and Yeesoonsang, Seesai and Sornwong, Kanlaya and Sonthichai, Chaninan and Chard, Anna N and Davis, William W and Montgomery, Martha P and Prasert, Kriengkrai},
  title = {Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand},
  journal = {American Journal of Epidemiology},
  year = {2026},
  doi = {10.1093/aje/kwag094}
}
Kostenlos starten →